EverlyWell is a health care startup founded in 2015 that aims to revolutionize diagnostic testing by offering a wide range of DIY kits for at-home use. These kits cover various areas such as food sensitivity, fertility, hormones, STDs, thyroid, metabolism, and even COVID-19 testing. The company's slogan "Experience convenient at-home diagnostic testing with comprehensive results available on your mobile device" reflects its commitment to bringing convenience and accessibility to healthcare. By enabling individuals to conduct tests in the comfort of their homes and receive physician-reviewed results and insights directly on their mobile devices, EverlyWell is tapping into the growing trend of telemedicine and personalized health. The company's recent secondary market investment of $75.00M by HealthQuest Capital on 17 January 2021 underscores the confidence of investors in its business model and potential for growth. With the increasing demand for at-home diagnostic solutions, EverlyWell is well-positioned to capitalize on this market opportunity and continue making an impact in the health tech industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Secondary Market | $75.00M | 1 | 17 Jan 2021 | |
Series D | $175.00M | 10 | Trish Costello | 03 Dec 2020 |
Series C | $25.00M | 1 | 01 Feb 2020 | |
Venture Round | $50.00M | 4 | 16 Apr 2019 | |
Series B | Unknown | 1 | Craig Barrett | 04 Oct 2018 |
No recent news or press coverage available for EverlyWell.